Fenwick’s Going Public Report: Covering U.S. Technology and Life Sciences IPOs, de-SPAC Mergers and Direct Listings - 2021 H1

Fenwick & West LLP
Contact

Technology and life sciences companies went public at an extraordinary rate in the first half of 2021 and they continued to do so via different paths: initial public offerings, de-SPAC mergers and direct listings.

Our report focuses on U.S. and foreign technology and life sciences companies that went public in the U.S. in the first half of 2021.

Key highlights include:

- IPOs outpaced the second half of 2020, which was previously the most active six months for the space since we began tracking in 2012.

- The de-SPAC (special purpose acquisition company) merger surge also continued: the number of tech and life sciences companies to go public via SPAC merger in the first half of 2021 increased 71 percent from the second half of 2020.

- The four direct listings in H1 2021 were double the number in the previous half year and included Fenwick client Coinbase Global’s blockbuster Nasdaq direct listing.

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Fenwick & West LLP

Written by:

Fenwick & West LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Fenwick & West LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide